GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma
Status:
Unknown status
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase I clinical study for evaluating the safety, pharmacokinetics, and preliminary
efficacy of repeated doses, dose escalation of GR1405 injection in patients with advanced
solid tumor or lymphoma